Race and Sex Differences in the Incidence and Prognostic Significance of Silent Myocardial Infarction in the Atherosclerosis Risk in Communities (ARIC) Study
暂无分享,去创建一个
David Couper | Elsayed Z Soliman | Pentti M Rautaharju | D. Couper | W. Rosamond | E. Soliman | D. Kitzman | R. Prineas | P. Rautaharju | C. Rodriguez | L. Loehr | Ronald J Prineas | Wayne D Rosamond | Zhu-Ming Zhang | Laura Loehr | Zhu-ming Zhang | Carlos J Rodriguez | Dalane Kitzman
[1] J. Kors,et al. Echocardiographic characteristics of electrocardiographically unrecognized myocardial infarctions in a community population. , 2005, The American journal of cardiology.
[2] J. Neaton,et al. Unrecognized myocardial infarction: experience in the multiple risk factor intervention trial (MRFIT) , 1987, Circulation.
[3] Mark D. Huffman,et al. AHA Statistical Update Heart Disease and Stroke Statistics — 2012 Update A Report From the American Heart Association WRITING GROUP MEMBERS , 2010 .
[4] M. Whooley,et al. Prognostic value of electrocardiographic detection of unrecognized myocardial infarction in persons with stable coronary artery disease: data from the Heart and Soul Study , 2010, Clinical Research in Cardiology.
[5] M. Laakso,et al. Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. , 2010, European heart journal.
[6] G. Thorgeirsson,et al. Unrecognized Myocardial Infarction: Epidemiology, Clinical Characteristics, and the Prognostic Role of Angina Pectoris: The Reykjavik Study , 1995, Annals of Internal Medicine.
[7] A. Folsom,et al. Occurrence of unrecognized myocardial infarction in subjects aged 45 to 65 years (the ARIC study). , 2002, The American journal of cardiology.
[8] S Hulley,et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. , 1998, JAMA.
[9] Roger B. Davis,et al. Impact of Unrecognized Myocardial Scar Detected by Cardiac Magnetic Resonance Imaging on Event-Free Survival in Patients Presenting With Signs or Symptoms of Coronary Artery Disease , 2006, Circulation.
[10] A. Folsom,et al. Twenty-Two–Year Trends in Incidence of Myocardial Infarction, Coronary Heart Disease Mortality, and Case Fatality in 4 US Communities, 1987–2008 , 2012, Circulation.
[11] Kannel Wb. Prevalence and clinical aspects of unrecognized myocardial infarction and sudden unexpected death. , 1987 .
[12] P J Hannan,et al. Prognostic associations of Minnesota Code serial electrocardiographic change classification with coronary heart disease mortality in the Multiple Risk Factor Intervention Trial. , 1997, The American journal of cardiology.
[13] B. Gersh,et al. Prevalence, predisposing factors, and prognosis of clinically unrecognized myocardial infarction in the elderly. , 2000, Journal of the American College of Cardiology.
[14] K. Yano,et al. The incidence and prognosis of unrecognized myocardial infarction in the Honolulu, Hawaii, Heart Program. , 1989, Archives of internal medicine.
[15] B. Gersh,et al. Unrecognized Myocardial Infarction , 2001, Annals of Internal Medicine.
[16] W. L. Ooi,et al. Prevalence, incidence and prognosis of recognized and unrecognized myocardial infarction in persons aged 75 years or older: The Bronx Aging Study. , 1990, The American journal of cardiology.
[17] V. Seutin,et al. Pirlindole and dehydropirlindole protect rat cultured neuronal cells against oxidative stress‐induced cell death through a mechanism unrelated to MAO‐A inhibition , 2002, British journal of pharmacology.
[18] L. S. Jónsdóttir,et al. Incidence and prevalence of recognised and unrecognised myocardial infarction in women. The Reykjavik Study. , 1998, European heart journal.
[19] M. Pfeffer,et al. Clinically unrecognized Q-wave myocardial infarction in patients with diabetes mellitus, systemic hypertension, and nephropathy. , 2004, The American journal of cardiology.
[20] T. Davis,et al. Silent myocardial infarction and its prognosis in a community-based cohort of Type 2 diabetic patients: the Fremantle Diabetes Study , 2004, Diabetologia.
[21] W. Kannel,et al. Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study. , 1984, The New England journal of medicine.
[22] W. Kannel,et al. Clinical features of unrecognized myocardial infarction--silent and symptomatic. Eighteen year follow-up: the Framingham study. , 1973, The American journal of cardiology.
[23] J. Alpert,et al. Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction , 2008 .
[24] J. Medalie,et al. Unrecognized myocardial infarction: five-year incidence, mortality, and risk factors. , 1976, Annals of internal medicine.
[25] M. Hlatky,et al. The Incidence of Unrecognized Myocardial Infarction in Women with Coronary Heart Disease , 2001, Annals of Internal Medicine.
[26] A. Marty. Minnesota Code Manual of Electrocardiographic Findings , 1983 .
[27] J. Alpert,et al. Universal definition of myocardial infarction. , 2007, European heart journal.
[28] W. Kannel,et al. Prognosis after initial myocardial infarction: the Framingham study. , 1979, The American journal of cardiology.
[29] C. Lewis,et al. Association of race and sex with risk of incident acute coronary heart disease events. , 2012, JAMA.
[30] O. Jolobe. Incidence of recognized and unrecognized myocardial infarction in men and women aged 55 and older: the Rotterdam Study. , 2006, European heart journal.
[31] C. Gibson,et al. Prevalence, consequences, and implications for clinical trials of unrecognized myocardial infarction. , 2013, The American journal of cardiology.
[32] Fred S Apple,et al. Third universal definition of myocardial infarction , 2012 .
[33] A. Folsom,et al. Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years' experience. , 1996, Journal of clinical epidemiology.
[34] A. Folsom,et al. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. , 1989, American journal of epidemiology.
[35] T. Dawber,et al. The silent coronary: the frequency and clinical characteristics of unrecognized myocardial infarction in the Framingham study. , 1959, Annals of internal medicine.
[36] D. Spodick,et al. The incidence and prognosis of unrecognized myocardial infarction. , 1990, Archives of internal medicine.
[37] C. Jenkins,et al. Clinically unrecognized myocardial infarction in the Western Collaborative Group Study. , 1967, The American journal of cardiology.
[38] W. Kannel,et al. The unrecognized myocardial infarction. Fourteen-year follow-up experience in the Framingham study. , 1970, Geriatrics.
[39] W. Kannel,et al. Incidence, precursors and prognosis of unrecognized myocardial infarction. , 1990, Advances in cardiology.
[40] W. Kannel. Prevalence and clinical aspects of unrecognized myocardial infarction and sudden unexpected death , 1987, Circulation.